Biblio
Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells. J Nanobiotechnology. 2023;21(1):154.
. Stem cells therapy for diabetes: from past to future. Cytotherapy. 2023.
. .
.
.
.
.